Seth A Goldberg

June 06, 2018 | National Law Journal

The rescission of the Cole Priorities has stifled that progress. Consequently, the risks to public safety of a multibillion-dollar cash industry and opaque maneuvers to transfer cannabis are omnipresent in the cannabis industry.

By Seth A. Goldberg

1 minute read

May 22, 2018 | The Legal Intelligencer

Let's say ABC LLC applied for and was granted permits to grow, process and dispense cannabis pursuant to its state's medical marijuana regulations. ABC now operates a 120,000-square-foot cultivation facility and sells its cannabis-related products, which include THC and CBD vape oils, tinctures and pills, through three dispensaries.

By Seth A. Goldberg

10 minute read

October 13, 2016 | The Legal Intelligencer

In a closely watched case, the U.S. Court of Appeals for the Third Circuit recently moved to halt the proposed merger of Penn State Hershey Medical Center and PinnacleHealth System in Federal Trade Commission v. Penn State Hershey Medical Center, No. 16-2365, slip op. (3d Cir. Sept. 27). Since December 2015, when the Federal Trade Commission (FTC) and the commonwealth of Pennsylvania joined forces to formally oppose the merger in court, health care industry stakeholders have eagerly awaited developments in the case. In May, the U.S. District Court for the Middle District of Pennsylvania issued a sharp rebuke of the FTC, denying its request for a preliminary injunction. The tides turned recently, however, when the Third Circuit reversed the decision and ordered the lower court to preliminarily enjoin the proposed merger pending completion of the FTC's administrative review of the merger.

By Seth A. Goldberg 
and Alison T. Rosenblum

16 minute read

December 10, 2014 | The Legal Intelligencer

The Controlled Substances Act, 21 U.S.C. Section 811 et. seq. (CSA), enacted in 1970, provides that marijuana is a "Schedule I" drug because, in the words of the CSA, it has a "high potential for abuse," "no currently accepted medical use in treatment," and "there is a lack of accepted safety for use … under medical supervision." Accordingly, under the CSA, it is unlawful to "manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense," marijuana in any form.

By Seth A. Goldberg and Philip H. Lebowitz

8 minute read

August 25, 2014 | Corporate Counsel

Counsel who are adroit in diplomacy and can manage various interested groups stand the best chance of resolving an enforcement action against an executive.

By Seth A. Goldberg and Matthew A. Taylor

9 minute read

May 29, 2014 | Corporate Counsel

An enforcement agency investigation targeting an executive requires a company and its counsel to blend large doses of diplomacy with legal substance.

By Seth A. Goldberg and Matthew A. Taylor

9 minute read